{
  "_originalData": {
    "identity": {
      "bacteriumName": "Chlamydia pneumoniae",
      "aliases": [
        "Chlamydophila pneumoniae"
      ],
      "lastUpdated": "2024-05-13",
      "clsiCategory": "Not classified by CLSI",
      "classification": {
        "gramStain": "Not applicable (does not Gram stain)",
        "morphology": "Coccobacillus",
        "respiration": "Aerobic",
        "notes": [
          "Obligate intracellular bacterium"
        ]
      },
      "strainDetails": [],
      "biochemicalTests": "Obligate intracellular bacterium; cannot be Gram-stained or cultured on standard media. Identification is by serology or nucleic acid amplification tests (NAATs)."
    },
    "clinicalProfile": {
      "summary": "Chlamydia pneumoniae is a common cause of atypical community-acquired pneumonia. The illness is often mild, characterized by a non-productive cough and sore throat.",
      "pathophysiologyPearls": [
        "Infection occurs via respiratory droplets and the organism replicates within host cells, leading to inflammation of the respiratory tract."
      ],
      "keySignsAndSymptoms": [
        "Non-productive cough",
        "Sore throat",
        "Hoarseness",
        "Low-grade fever",
        "Headache"
      ],
      "clinicalSyndromes": [
        {
          "syndromeName": "Atypical Pneumonia",
          "description": "A form of community-acquired pneumonia with a subacute onset and often milder symptoms than typical bacterial pneumonia."
        },
        {
          "syndromeName": "Bronchitis",
          "description": "Inflammation of the bronchial tubes, leading to cough."
        },
        {
          "syndromeName": "Pharyngitis",
          "description": "Inflammation of the pharynx, causing a sore throat."
        }
      ],
      "highRiskPopulations": [],
      "transmissionVectors": [
        "Respiratory droplets"
      ],
      "prognosisNotes": []
    },
    "resistanceProfile": {
      "groupIntrinsicResistance": [],
      "intrinsicResistance": [],
      "majorMechanisms": [],
      "clinicalAlerts": []
    },
    "treatment": {
      "generalNotes": [
        "The following regimens are for microbiologically confirmed infections."
      ],
      "drugsToAvoid": [],
      "adjunctiveTherapies": [],
      "regimens": [
        {
          "context": {
            "type": "Directed",
            "condition": "Atypical Pneumonia",
            "patientPopulation": [
              "General"
            ],
            "isolateSource": null
          },
          "recommendations": [
            {
              "preference": "Primary",
              "strategy": "Monotherapy",
              "steps": [
                {
                  "step": 1,
                  "duration": "14 days",
                  "drugs": [
                    {
                      "drugName": "Doxycycline",
                      "dose": "100 mg",
                      "route": "PO/IV",
                      "frequency": "BID",
                      "comments": ""
                    }
                  ]
                }
              ],
              "notes": []
            },
            {
              "preference": "Primary",
              "strategy": "Sequential",
              "steps": [
                {
                  "step": 1,
                  "duration": "1 day",
                  "drugs": [
                    {
                      "drugName": "Azithromycin",
                      "dose": "500 mg",
                      "route": "PO/IV",
                      "frequency": "once",
                      "comments": ""
                    }
                  ]
                },
                {
                  "step": 2,
                  "duration": "4 days",
                  "drugs": [
                    {
                      "drugName": "Azithromycin",
                      "dose": "250 mg",
                      "route": "PO",
                      "frequency": "daily",
                      "comments": ""
                    }
                  ]
                }
              ],
              "notes": []
            },
            {
              "preference": "Alternative",
              "strategy": "Monotherapy",
              "steps": [
                {
                  "step": 1,
                  "duration": "5-7 days",
                  "drugs": [
                    {
                      "drugName": "Levofloxacin",
                      "dose": "750 mg",
                      "route": "PO/IV",
                      "frequency": "daily",
                      "comments": ""
                    }
                  ]
                }
              ],
              "notes": []
            },
            {
              "preference": "Alternative",
              "strategy": "Monotherapy",
              "steps": [
                {
                  "step": 1,
                  "duration": "10 days",
                  "drugs": [
                    {
                      "drugName": "Clarithromycin",
                      "dose": "500 mg",
                      "route": "PO",
                      "frequency": "BID",
                      "comments": ""
                    }
                  ]
                }
              ],
              "notes": []
            },
            {
              "preference": "Alternative",
              "strategy": "Monotherapy",
              "steps": [
                {
                  "step": 1,
                  "duration": "7-14 days",
                  "drugs": [
                    {
                      "drugName": "Omadacycline",
                      "dose": "See comments",
                      "route": "IV/PO",
                      "frequency": "q24h",
                      "comments": "IV: 200 mg IV loading dose then 100 mg q24h, OR 100 mg IV BID on day 1 then 100 mg IV q24h. PO: 450 mg PO q24h on days 1-2 then 300 mg PO q24h."
                    }
                  ]
                }
              ],
              "notes": []
            }
          ]
        }
      ]
    },
    "laboratoryProfile": {
      "testingIndications": [
        "Patients with community-acquired pneumonia, particularly with atypical features."
      ],
      "methodologyNotes": [
        "Serological tests are cross-reactive between C. psittaci and C. pneumoniae."
      ],
      "recommendedPanel": [],
      "specialTests": [
        {
          "testName": "Nucleic Acid Amplification Test (NAAT)",
          "trigger": "Suspicion of Chlamydia pneumoniae infection",
          "purpose": "To detect C. pneumoniae genetic material in respiratory specimens. The FilmArray Respiratory Panel is an FDA-approved example."
        },
        {
          "testName": "Serology",
          "trigger": "Suspicion of Chlamydia pneumoniae infection",
          "purpose": "To detect antibodies to C. pneumoniae. Paired acute and convalescent sera are recommended."
        }
      ],
      "reportingRules": [],
      "antimicrobialBreakpoints": []
    },
    "additionalInformation": {
      "diagnosticNotes": {
        "summary": "Diagnosis is typically made by NAAT on respiratory samples. Serology can be used but has limitations.",
        "biosafetyWarning": "Standard precautions are sufficient for handling clinical specimens.",
        "methods": [
          {
            "methodName": "NAAT",
            "details": "Highly sensitive and specific for the detection of C. pneumoniae."
          },
          {
            "methodName": "Serology",
            "details": "Can be used for diagnosis, but cross-reactivity with other Chlamydia species is a concern."
          }
        ]
      },
      "preventionAndScreening": [],
      "treatmentLifecycle": [],
      "antimicrobialStewardship": [],
      "drugSpecificPearls": [],
      "guidelineReferences": [
        {
          "source": "N Engl J Med",
          "citation": "2019 Feb 7; 380(6):517-527",
          "summaryOrNote": "Review of community-acquired pneumonia."
        },
        {
          "source": "StatPearls",
          "citation": "2022 Jan. 2022 Aug 8",
          "summaryOrNote": "Review of Chlamydia pneumoniae infection."
        }
      ]
    }
  },
  "_metadata": {
    "originalKeys": [
      "identity",
      "clinicalProfile",
      "resistanceProfile",
      "treatment",
      "laboratoryProfile",
      "additionalInformation"
    ],
    "conversionTimestamp": "2025-07-15T03:16:49.367Z",
    "sourceFormat": "modern"
  },
  "identity": {
    "bacteriumName": {
      "sources": [
        "identity.bacteriumName"
      ],
      "value": "Chlamydia pneumoniae"
    },
    "aliases": {
      "sources": [
        "identity.aliases"
      ],
      "value": [
        "Chlamydophila pneumoniae"
      ]
    },
    "lastUpdated": {
      "sources": [
        "identity.lastUpdated"
      ],
      "value": "2024-05-13"
    },
    "classification": {
      "sources": [
        "identity.classification"
      ],
      "value": {
        "gramStain": "Not applicable (does not Gram stain)",
        "morphology": "Coccobacillus",
        "respiration": "Aerobic",
        "notes": [
          "Obligate intracellular bacterium"
        ]
      }
    }
  },
  "clinicalInformation": {
    "sources": [
      "clinicalProfile"
    ],
    "value": {
      "summary": "Chlamydia pneumoniae is a common cause of atypical community-acquired pneumonia. The illness is often mild, characterized by a non-productive cough and sore throat.",
      "pathophysiologyPearls": [
        "Infection occurs via respiratory droplets and the organism replicates within host cells, leading to inflammation of the respiratory tract."
      ],
      "keySignsAndSymptoms": [
        "Non-productive cough",
        "Sore throat",
        "Hoarseness",
        "Low-grade fever",
        "Headache"
      ],
      "clinicalSyndromes": [
        {
          "syndromeName": "Atypical Pneumonia",
          "description": "A form of community-acquired pneumonia with a subacute onset and often milder symptoms than typical bacterial pneumonia."
        },
        {
          "syndromeName": "Bronchitis",
          "description": "Inflammation of the bronchial tubes, leading to cough."
        },
        {
          "syndromeName": "Pharyngitis",
          "description": "Inflammation of the pharynx, causing a sore throat."
        }
      ],
      "highRiskPopulations": [],
      "transmissionVectors": [
        "Respiratory droplets"
      ],
      "prognosisNotes": []
    }
  },
  "resistanceInformation": {
    "sources": [
      "resistanceProfile"
    ],
    "value": {
      "groupIntrinsicResistance": [],
      "intrinsicResistance": [],
      "majorMechanisms": [],
      "clinicalAlerts": []
    }
  },
  "treatmentData": {
    "treatmentData": {
      "_treatmentMetadata": {
        "originalFormat": "modern"
      },
      "standardizedRegimens": [
        {
          "regimenId": "modern-0-0-0",
          "extractedFrom": "treatment.regimens[0].recommendations[0].steps[0]",
          "context": {
            "type": "directed",
            "condition": "Atypical Pneumonia",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "General"
              ],
              "labFindings": null
            }
          },
          "preference": "primary",
          "drugs": [
            {
              "drugName": "Doxycycline",
              "dose": "100 mg",
              "route": "PO/IV",
              "frequency": "BID",
              "duration": "14 days",
              "comments": "",
              "originalText": "Doxycycline 100 mg PO/IV BID"
            }
          ]
        },
        {
          "regimenId": "modern-0-1-0",
          "extractedFrom": "treatment.regimens[0].recommendations[1].steps[0]",
          "context": {
            "type": "directed",
            "condition": "Atypical Pneumonia",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "General"
              ],
              "labFindings": null
            }
          },
          "preference": "primary",
          "drugs": [
            {
              "drugName": "Azithromycin",
              "dose": "500 mg",
              "route": "PO/IV",
              "frequency": "once",
              "duration": "1 day",
              "comments": "",
              "originalText": "Azithromycin 500 mg PO/IV once"
            }
          ]
        },
        {
          "regimenId": "modern-0-1-1",
          "extractedFrom": "treatment.regimens[0].recommendations[1].steps[1]",
          "context": {
            "type": "directed",
            "condition": "Atypical Pneumonia",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "General"
              ],
              "labFindings": null
            }
          },
          "preference": "primary",
          "drugs": [
            {
              "drugName": "Azithromycin",
              "dose": "250 mg",
              "route": "PO",
              "frequency": "daily",
              "duration": "4 days",
              "comments": "",
              "originalText": "Azithromycin 250 mg PO daily"
            }
          ]
        },
        {
          "regimenId": "modern-0-2-0",
          "extractedFrom": "treatment.regimens[0].recommendations[2].steps[0]",
          "context": {
            "type": "directed",
            "condition": "Atypical Pneumonia",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "General"
              ],
              "labFindings": null
            }
          },
          "preference": "alternative",
          "drugs": [
            {
              "drugName": "Levofloxacin",
              "dose": "750 mg",
              "route": "PO/IV",
              "frequency": "daily",
              "duration": "5-7 days",
              "comments": "",
              "originalText": "Levofloxacin 750 mg PO/IV daily"
            }
          ]
        },
        {
          "regimenId": "modern-0-3-0",
          "extractedFrom": "treatment.regimens[0].recommendations[3].steps[0]",
          "context": {
            "type": "directed",
            "condition": "Atypical Pneumonia",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "General"
              ],
              "labFindings": null
            }
          },
          "preference": "alternative",
          "drugs": [
            {
              "drugName": "Clarithromycin",
              "dose": "500 mg",
              "route": "PO",
              "frequency": "BID",
              "duration": "10 days",
              "comments": "",
              "originalText": "Clarithromycin 500 mg PO BID"
            }
          ]
        },
        {
          "regimenId": "modern-0-4-0",
          "extractedFrom": "treatment.regimens[0].recommendations[4].steps[0]",
          "context": {
            "type": "directed",
            "condition": "Atypical Pneumonia",
            "severity": "unknown",
            "patientFactors": {
              "population": [
                "General"
              ],
              "labFindings": null
            }
          },
          "preference": "alternative",
          "drugs": [
            {
              "drugName": "Omadacycline",
              "dose": "See comments",
              "route": "IV/PO",
              "frequency": "q24h",
              "duration": "7-14 days",
              "comments": "IV: 200 mg IV loading dose then 100 mg q24h, OR 100 mg IV BID on day 1 then 100 mg IV q24h. PO: 450 mg PO q24h on days 1-2 then 300 mg PO q24h.",
              "originalText": "Omadacycline See comments IV/PO q24h"
            }
          ]
        }
      ]
    }
  },
  "laboratoryData": {
    "sources": [
      "laboratoryProfile"
    ],
    "value": {
      "testingIndications": [
        "Patients with community-acquired pneumonia, particularly with atypical features."
      ],
      "methodologyNotes": [
        "Serological tests are cross-reactive between C. psittaci and C. pneumoniae."
      ],
      "recommendedPanel": [],
      "specialTests": [
        {
          "testName": "Nucleic Acid Amplification Test (NAAT)",
          "trigger": "Suspicion of Chlamydia pneumoniae infection",
          "purpose": "To detect C. pneumoniae genetic material in respiratory specimens. The FilmArray Respiratory Panel is an FDA-approved example."
        },
        {
          "testName": "Serology",
          "trigger": "Suspicion of Chlamydia pneumoniae infection",
          "purpose": "To detect antibodies to C. pneumoniae. Paired acute and convalescent sera are recommended."
        }
      ],
      "reportingRules": [],
      "antimicrobialBreakpoints": []
    }
  },
  "additionalData": {
    "antimicrobialStewardship": {
      "sources": [
        "antimicrobial_stewardship",
        "antimicrobialStewardship"
      ],
      "value": []
    },
    "comments": {
      "preservedStructure": {
        "originalFormat": "object"
      }
    },
    "diagnosis": {
      "sources": [
        "diagnosis"
      ],
      "value": []
    },
    "allOtherKeys": {}
  }
}